Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Role of co-expression of c-Myc, EZH2 and p27 in prognosis of prostate cancer patients after surgery.

Li K, Chen MK, Situ J, Huang WT, Su ZL, He D, Gao X.

Chin Med J (Engl). 2013 Jan;126(1):82-7.

PMID:
23286483
[PubMed - indexed for MEDLINE]
Free Article
2.

The value of EZH2, p27(kip1), BMI-1 and MIB-1 on biopsy specimens with low-risk prostate cancer in selecting men with significant prostate cancer at prostatectomy.

Wolters T, Vissers KJ, Bangma CH, Schröder FH, van Leenders GJ.

BJU Int. 2010 Jul;106(2):280-6. doi: 10.1111/j.1464-410X.2009.08998.x. Epub 2009 Nov 3.

PMID:
19888978
[PubMed - indexed for MEDLINE]
3.

Low p27 expression predicts poor disease-free survival in patients with prostate cancer.

Yang RM, Naitoh J, Murphy M, Wang HJ, Phillipson J, deKernion JB, Loda M, Reiter RE.

J Urol. 1998 Mar;159(3):941-5.

PMID:
9474188
[PubMed - indexed for MEDLINE]
4.

Low p27 expression predicts biochemical relapse after radical prostatectomy in patients with clinically localised prostate cancer.

Ribal MJ, Fernandez PL, Lopez-Guillermo A, Farré X, Santos Y, Gibanel R, Cardesa A, Alcaraz A.

Anticancer Res. 2003 Nov-Dec;23(6D):5101-6.

PMID:
14981973
[PubMed - indexed for MEDLINE]
5.

Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.

Kupelian PA, Katcher J, Levin HS, Klein EA.

Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):1043-52.

PMID:
9169811
[PubMed - indexed for MEDLINE]
6.

Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.

Bland KI, Konstadoulakis MM, Vezeridis MP, Wanebo HJ.

Ann Surg. 1995 Jun;221(6):706-18; discussion 718-20.

PMID:
7794075
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer.

Vis AN, Noordzij MA, Fitoz K, Wildhagen MF, Schröder FH, van der Kwast TH.

J Urol. 2000 Dec;164(6):2156-61.

PMID:
11061947
[PubMed - indexed for MEDLINE]
8.

Combined c-Myc and caveolin-1 expression in human prostate carcinoma predicts prostate carcinoma progression.

Yang G, Timme TL, Frolov A, Wheeler TM, Thompson TC.

Cancer. 2005 Mar 15;103(6):1186-94.

PMID:
15712208
[PubMed - indexed for MEDLINE]
Free Article
9.

An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomy.

Antonarakis ES, Keizman D, Zhang Z, Gurel B, Lotan TL, Hicks JL, Fedor HL, Carducci MA, De Marzo AM, Eisenberger MA.

Cancer. 2012 Dec 15;118(24):6063-71. doi: 10.1002/cncr.27689. Epub 2012 Jun 6.

PMID:
22674438
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Role of p21(WAF1) and p27(KIP1) in predicting biochemical recurrence for organ-confined prostate adenocarcinoma.

Wu TT, Wang JS, Jiaan BP, Yu CC, Tsai JY, Lin JT, Huang JK.

J Chin Med Assoc. 2007 Jan;70(1):11-5.

PMID:
17276927
[PubMed - indexed for MEDLINE]
11.

Association of p27Kip1 levels with recurrence and survival in patients with stage C prostate carcinoma.

Cote RJ, Shi Y, Groshen S, Feng AC, Cordon-Cardo C, Skinner D, Lieskovosky G.

J Natl Cancer Inst. 1998 Jun 17;90(12):916-20.

PMID:
9637141
[PubMed - indexed for MEDLINE]
Free Article
12.

Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer.

Rhodes DR, Sanda MG, Otte AP, Chinnaiyan AM, Rubin MA.

J Natl Cancer Inst. 2003 May 7;95(9):661-8.

PMID:
12734317
[PubMed - indexed for MEDLINE]
Free Article
13.

Validation of stem cell markers in clinical prostate cancer: α6-integrin is predictive for non-aggressive disease.

Hoogland AM, Verhoef EI, Roobol MJ, Schröder FH, Wildhagen MF, van der Kwast TH, Jenster G, van Leenders GJ.

Prostate. 2014 May;74(5):488-96. doi: 10.1002/pros.22768. Epub 2013 Dec 27.

PMID:
24375374
[PubMed - indexed for MEDLINE]
14.

8q24 amplification is associated with Myc expression and prostate cancer progression and is an independent predictor of recurrence after radical prostatectomy.

Fromont G, Godet J, Peyret A, Irani J, Celhay O, Rozet F, Cathelineau X, Cussenot O.

Hum Pathol. 2013 Aug;44(8):1617-23. doi: 10.1016/j.humpath.2013.01.012. Epub 2013 Apr 8.

PMID:
23574779
[PubMed - indexed for MEDLINE]
15.

Predicting biochemical recurrence after radical prostatectomy for patients with organ-confined disease using p27 expression.

Freedland SJ, de Gregorio F, Sacoolidge JC, Elshimali YI, Csathy GS, Elashoff DA, Reiter RE, Aronson WJ.

Urology. 2003 Jun;61(6):1187-92.

PMID:
12809895
[PubMed - indexed for MEDLINE]
16.

Preoperative prostate needle biopsy p27 correlates with subsequent radical prostatectomy p27, Gleason grade and pathological stage.

Thomas GV, Schrage MI, Rosenfelt L, Kim JH, Salur G, deKernion JB, Dorey F, Said J, Reiter RE.

J Urol. 2000 Dec;164(6):1987-91.

PMID:
11061897
[PubMed - indexed for MEDLINE]
17.

Differential expression of Pim-3, c-Myc, and p-p27 proteins in adenocarcinomas of the gastric cardia and distal stomach.

Lou L, Wang Y, Cui J, Yan X, Xue L, Li Y.

Tumour Biol. 2014 May;35(5):5029-36. doi: 10.1007/s13277-014-1664-z. Epub 2014 Feb 2.

PMID:
24488669
[PubMed - indexed for MEDLINE]
18.

The predictive value of semaphorins 3 expression in biopsies for biochemical recurrence of patients with low- and intermediate-risk prostate cancer.

Li K, Chen MK, Li LY, Lu MH, Shao ChK, Su ZL, He D, Pang J, Gao X.

Neoplasma. 2013;60(6):683-9. doi: 10.4149/neo_2013_087.

PMID:
23906303
[PubMed - indexed for MEDLINE]
19.

Expression of cell cycle regulators p21 and p27 as predictors of disease outcome in colorectal carcinoma.

Al-Maghrabi J, Al-Ahwal M, Buhmeida A, Syrjänen K, Sibyani A, Emam E, Ghanim A, Al-Qahtani M.

J Gastrointest Cancer. 2012 Jun;43(2):279-87. doi: 10.1007/s12029-011-9292-y.

PMID:
21637966
[PubMed - indexed for MEDLINE]
20.

Expression of cell-cycle-regulated proteins pRb2/p130, p107, p27(kip1), p53, mdm-2, and Ki-67 (MIB-1) in prostatic gland adenocarcinoma.

Claudio PP, Zamparelli A, Garcia FU, Claudio L, Ammirati G, Farina A, Bovicelli A, Russo G, Giordano GG, McGinnis DE, Giordano A, Cardi G.

Clin Cancer Res. 2002 Jun;8(6):1808-15.

PMID:
12060621
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk